Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > LLY Eli Lilly and Co > Main Composition
LLY Eli Lilly and Co
371.790
-0.180-0.05%
Post Mkt Price
371.7900.0000.00%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
other--7.49B26.44%
Trulicity--6.47B22.85%
Humalog--2.45B8.66%
COVID-19 Antibodies--2.24B7.91%
Taltz--2.21B7.81%
Alimta--2.06B7.28%
Jardiance--1.49B5.26%
Verzenio--1.35B4.77%
Other products--1.33B4.69%
Humulin--1.22B4.32%
View all
Region Unit:USD
nameYOYOperating income%
United States--16.81B59.36%
Europe--4.78B16.87%
Other foreign countries--2.7B9.54%
Japan--2.37B8.36%
China--1.66B5.87%
Company Overview More
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
CEO: Mr. David A. Ricks
Market: NYSE
Listing Date: 04/01/1973
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist